Intended Use

syngo.via molecular imaging (MI) workflows comprise medical diagnostic applications for viewing, manipulation, quantification, analysis and comparison of medical images from single or multiple imaging modalities with one or more time-points, including functional and anatomical datasets to aid in disease management and radiotherapy planning.

Technology

Software-only medical device that provides multi-modality post-processing capabilities for functional and anatomical imaging data, running on IT hardware via the Siemens syngo.via platform. Features include workflow-specific tools for oncology, cardiology, and neurology such as image visualization, segmentation, quantification, and database comparison across PET, CT, MRI, and SPECT modalities.

Performance

Comprehensive software validation including verification and validation tests ensuring functionality as designed, performance requirements met, and hazard mitigations fully implemented. Risk management follows ISO 14971 and standards IEC 62304, EN ISO 13485. Cybersecurity controls are implemented per FDA guidance to prevent unauthorized access and data misuse.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    5/11/2021

    1 month
  • 2

    FDA Approval

    6/10/2021

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.